Long‐term outcomes of a cohort of patients with pharmacoresistant neonatal epilepsy and negative brain <scp>MRI</scp>
Our study found that epilepsy starting in the neonatal period is often linked to a strong genetic component. The prognosis is generally poor, with frequent neurodevelopmental delays. An abnormal neurological examination during the neonatal period is a predictor of worse outcomes.
Authors
- Béatrice Desnous (ORCID: https://orcid.org/0000-0003-2571-8564)
- Laurent Villard (ORCID: https://orcid.org/0000-0001-6657-5008)
- William Rozalen
- Florence Riccardi (ORCID: https://orcid.org/0000-0002-7223-2172)
- Thibault Beretti
- Nathalie Villeneuve (ORCID: https://orcid.org/0000-0003-1584-8314)
- Géraldine Daquin
- Mathieu Milh (ORCID: https://orcid.org/0000-0002-2454-8543)
- Anne Lépine (ORCID: https://orcid.org/0000-0002-9844-9687)
Institutions
- Inserm (FR)
- Aix-Marseille Université (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Hôpital de la Conception (FR)
- Institut de Neurobiologie de la Méditerranée (FR)
- Centre Hospitalier Intercommunal Toulon-La Seyne-sur-Mer (FR)
- Hôpital de la Timone (FR)
Publication Details
- Journal
- Epilepsia Open
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1002/epi4.70126
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00